Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X:
“Can we truly label a study with Grade 5 toxicity as ‘acceptable’ or ‘manageable’?
My letter on the necessity of ‘redefining toxicity terminology in clinical trial reporting’ (original title).”
Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial
Source: Yakup Ergün/X